Gansevoort, R., Arici, M., Benzing, T., Birn, H., Capasso, G., Covic, A., . . . Van Biesen, W. (2016). Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: A position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice.
Citação norma ChicagoGansevoort, RT, et al. Recommendations for the Use of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Position Statement On Behalf of the ERA-EDTA Working Groups On Inherited Kidney Disorders and European Renal Best Practice. 2016.
Citação norma MLAGansevoort, RT, et al. Recommendations for the Use of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Position Statement On Behalf of the ERA-EDTA Working Groups On Inherited Kidney Disorders and European Renal Best Practice. 2016.